Lucid Diagnostics Inc (NAS:LUCD)
$ 0.788 0.021 (2.74%) Market Cap: 45.52 Mil Enterprise Value: 99.85 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 44/100

Q3 2023 Lucid Diagnostics Inc Earnings Call Transcript

Nov 14, 2023 / 01:30PM GMT
Release Date Price: $1.3 (+12.07%)
Operator

(inaudible) and welcome to Lucid Diagnostics third-quarter 2023 business update conference call. (Operator Instructions) Please note that this event is being recorded.

I would now like to turn the conference over to Michael Parks; VP, Investor Relations. Please go ahead.

Michael Parks
PAVmed Inc. - VP, IR

Thank you, operator, and good morning, everyone. Thank you for participating in today's third-quarter 2023 business update call.

The press release announcing our business update for the company and financial results for the three and nine months ended September 30, 2023, is available on the Lucid website. Please take a moment to read the disclaimer about forward-looking statements in this press release.

The business update, press release, and this conference call include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause the actual results to differ materially from statements made. Factors that could cause actual results to differ are described

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot